Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64,392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Visualizing in situ viral replication across the natural history of chronic HBV infection.
Zhang H, Zhang M, Zhang Q, Yu Y, Zhang F, Wang J, Zhou M, Yu T, Shen C, Yu S, Huang Y, Huang Y, Zhang J, Jin J, Qiu C, Guojun L, Zhang W. Zhang H, et al. Among authors: zhang m, zhang q, zhang f, zhang w, zhang j. Hepatol Commun. 2023 Mar 30;7(4):e0111. doi: 10.1097/HC9.0000000000000111. eCollection 2023 Apr 1. Hepatol Commun. 2023. PMID: 36995994 Free PMC article.
Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment-naïve chronic hepatitis B patients.
Zhang Q, Li G, Yu Y, Qiu C, Zheng J, Zhang H, Zhang M, Song Z, Yang Y, Du X, Hong J, Lu J, Li N, Tang Q, Xu L, Wang X, Huang Y, Zhang J, Chen Z, Zhang W. Zhang Q, et al. Among authors: zhang m, zhang w, zhang j, zhang h. J Viral Hepat. 2019 Jul;26 Suppl 1:59-68. doi: 10.1111/jvh.13153. J Viral Hepat. 2019. PMID: 31380588
Histological responses of peginterferon alpha add-on therapy in patients with chronic hepatitis B with advanced liver fibrosis after long-term nucleos(t)ide analog treatment.
Li G, Zhang Q, Yu Y, Qiu C, Zhang H, Zhang M, Song Z, Yang Y, Hong J, Lu J, Li N, Tang Q, Xu L, Wang X, Zhang W, Chen Z. Li G, et al. Among authors: zhang m, zhang q, zhang w, zhang h. J Viral Hepat. 2019 Jul;26 Suppl 1:50-58. doi: 10.1111/jvh.13152. J Viral Hepat. 2019. PMID: 31380590
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern.
Ai J, Zhang H, Zhang Q, Zhang Y, Lin K, Fu Z, Song J, Zhao Y, Fan M, Wang H, Qiu C, Zhou Y, Zhang W. Ai J, et al. Among authors: zhang q, zhang w, zhang h, zhang y. Cell Res. 2022 Jan;32(1):103-106. doi: 10.1038/s41422-021-00590-x. Epub 2021 Nov 23. Cell Res. 2022. PMID: 34815511 Free PMC article. No abstract available.
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.
Ai J, Zhang H, Zhang Y, Lin K, Zhang Y, Wu J, Wan Y, Huang Y, Song J, Fu Z, Wang H, Guo J, Jiang N, Fan M, Zhou Y, Zhao Y, Zhang Q, Liu Q, Lv J, Li P, Qiu C, Zhang W. Ai J, et al. Among authors: zhang q, zhang w, zhang h, zhang y. Emerg Microbes Infect. 2022 Dec;11(1):337-343. doi: 10.1080/22221751.2021.2022440. Emerg Microbes Infect. 2022. PMID: 34935594 Free PMC article.
Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.
Ai J, Wang J, Liu D, Xiang H, Guo Y, Lv J, Zhang Q, Li J, Zhang X, Li Q, Liang J, Guo X, Feng Y, Liu L, Zhang X, Qin W, Wang X, Rao W, Zhang Q, Tian Q, Zhang Y, Xie F, Jiang S, Yan Y, Qiu Y, Wu H, Hou Z, Zhang N, Zhang A, Ji J, Yang J, Huang J, Zhao Z, Gu Y, Bian L, Zhang Z, Zou S, Ji H, Ge G, Du X, Hou A, Zhu Y, Cong Q, Xu J, Zu H, Wang Y, Yan Z, Yan X, BianBa Y, Ci Q, Zhang L, Yang S, Gao X, Zhong L, He S, Liu C, Huang Y, Liu Y, Xu D, Zhu Q, Xu X, Lv M, Zhang W, Qi X. Ai J, et al. Among authors: zhang n, zhang l, zhang q, zhang a, zhang w, zhang z, zhang x, zhang y. Clin Gastroenterol Hepatol. 2022 Jul;20(7):1516-1524.e2. doi: 10.1016/j.cgh.2021.12.022. Epub 2021 Dec 20. Clin Gastroenterol Hepatol. 2022. PMID: 34942370 Free PMC article.
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study.
Ai J, Zhang Y, Zhang H, Zhang Q, Fu Z, Lin K, Song J, Zhao Y, Fan M, Wang H, Zhou Y, Chen X, Qiu C, Zhang W. Ai J, et al. Among authors: zhang q, zhang w, zhang h, zhang y. Emerg Microbes Infect. 2022 Dec;11(1):639-647. doi: 10.1080/22221751.2022.2025746. Emerg Microbes Infect. 2022. PMID: 35034582 Free PMC article.
64,392 results
You have reached the last available page of results. Please see the User Guide for more information.